Figure 2.

Canonical scores of 1st and 2nd variate transformed from Greene’s defined individual menopausal symptoms (GMS) for months 0 = Admission Point and after monthly (1 to 4) intake of Maca-GO capsules according to treatment sequence applied intermittently with Placebo and computed using the data from the previous part (1) and the present part of the study. (Data for treatment sequences within each of the computed encircled clusters displayed as the vectors of combined 21 GMS symptoms, when separated from each other, shows significant difference at the P<0.05 level).